# Arcade Therapeutics

> Arcade Therapeutics is a New York-based digital therapeutics company that builds clinically validated mobile games to treat mental illness. Founded by healthcare entrepreneur Raj Amin and neuroscientist Tracy Dennis-Tiwary, the company embeds a research-backed technique called attention bias modification into engaging games, starting with StarStarter for anxiety. Its lead prescription product, ABM-01, is pursuing FDA submission as one of the first game-based treatments for social anxiety disorder, with a pipeline extending to depression, addiction, and other conditions.

- **Founded:** 2015
- **Headquarters:** New York, New York, United States
- **Founders:** Raj Amin (Co-Founder & CEO), Tracy Dennis-Tiwary (Co-Founder & Chief Science Officer)
- **Team size:** ~11 employees
- **Products:** StarStarter, ABM-01 (StarStarter Rx), ABM-02
- **Notable:** Published a randomized controlled trial (n=104) in the Journal of Anxiety Disorders showing over 90% of participants reduced anxiety symptoms with a 33% average reduction., Won a $3.8M NIMH grant with UT Austin to test ABM-02 for major depressive disorder., Raised roughly $2M total in seed and grant funding, with backers including Reshma Saujani.

## Products & services

- **StarStarter** — A mobile wellness game for anxiety reduction that embeds attention bias modification, a clinically validated cognitive-training technique, into engaging gameplay.
- **ABM-01 (StarStarter Rx)** — A prescription digital therapeutic in clinical development for social anxiety disorder, positioned as one of the first game-based treatments for the condition and pursuing FDA submission.
- **ABM-02** — A game-based digital therapeutic in development for major depressive disorder, supported by a $3.8M NIMH grant and a large clinical trial with UT Austin.

## Achievements

- Published a randomized controlled trial (n=104) in the Journal of Anxiety Disorders showing over 90% of participants reduced anxiety symptoms with a 33% average reduction.
- Won a $3.8M NIMH grant with UT Austin to test ABM-02 for major depressive disorder.
- Raised roughly $2M total in seed and grant funding, with backers including Reshma Saujani.
- Rebranded from Wise Therapeutics to Arcade Therapeutics, repositioning as a science-first game studio.
- Advancing ABM-01 toward FDA submission as one of the first game-based treatments for social anxiety disorder.

## Latest updates

- **2025-03** — Published clinical study in the Journal of Anxiety Disorders showing StarStarter reduced social anxiety symptoms in over 90% of trial participants.
- **2024-02** — Closed a $1.5M seed round, bringing total funding to roughly $2M.
- **2023** — Announced a $3.8M NIMH grant with UT Austin to fund a large clinical trial of ABM-02 for major depressive disorder.

## Links

- Website: https://arcadetherapeutics.com
- LinkedIn: https://www.linkedin.com/company/arcade-therapeutics
- Twitter/X: https://x.com/ArcadeTherapeut
- YouTube: https://www.youtube.com/watch?v=16O84v1lynw
- Bluesky: https://bsky.app/profile/arcadetherapeutics.bsky.social
- Instagram: https://www.instagram.com/arcadetherapeutics/
- Facebook: https://www.facebook.com/ArcadeTherapeutics/
- TikTok: https://www.tiktok.com/@arcade.therapeutics

---

Profile page: https://yespress.io/arcade-therapeutics
Published by YesPress — https://yespress.io
Last updated: 2026-07-07